The senior director for preclinical translation discusses growing up in Scotland and London, discovering his love for science, and becoming an “accidental” cancer researcher committed to improving cancer care.
A novel oral combination drug therapy evaluated at Huntsman Cancer Institute could treat and prevent melanoma spreading to the brain. Brain metastasis is the main cause of death from melanoma.
Physician-scientist Conan Kinsey gives three reasons why pancreatic cancer has one of the lowest survival rates for any kind of cancer and explains how federally and donor-funded research provides hope.
New findings highlight the positive impact of personalized exercise programs for lung cancer patients undergoing surgery and how they directly enhance patient outcomes, particularly in women.
Genomic analyses funded by the National Cancer Institute show that ovarian cancer mutations are nearly identical across populations, yet some differences emerged. This information may be relevant for treatment decisions.
Three executive leaders describe how they see Huntsman Cancer Institute advancing cancer care and research in 2025 and beyond, including increasing cancer care access for all.
Alina Wilson, diagnosed with early-onset colorectal cancer, highlights the increasing prevalence of the disease in younger patients, its impact, and the ongoing research aimed at better treatment and understanding.
Huntsman Cancer Institute’s 2024 highlights of discovery and innovation include a new drug pairing for brain cancer, a groundbreaking study into health care barriers, and more.
Researchers at Huntsman Cancer Institute have found that fewer sessions of higher dose vaginal cuff brachytherapy work just as well as more frequent, lower-dose treatments for endometrial cancer patients.
Gita Suneja, MD, MSHP, shares her personal cancer story, her passion for fostering future researchers and investigators, and the importance of being an advocate for cancer patients.
Huntsman Cancer Institute joins with other institutions through myeloMATCH, a program that matches patients with clinical trials that specifically target their disease.
The latest advances in cancer research from Huntsman Cancer Institute include a new prostate cancer treatment, a method to predict aggressive breast cancer, and microbiome links to melanoma immunotherapy response.
A global study of a combination drug therapy, led by an investigator at Huntsman Cancer Institute, has shown improved overall survival rates for metastatic prostate cancer compared to standard treatments.
Ricky Harbison’s rare cancer diagnosis led him to Huntsman Cancer Institute and Helosia Soares, MD. Under her care and expertise, Ricky continues to enjoy the things he loves most.
State Senator Denise Hayman, dedicated advocate for the people of Montana, is being treated for a rare cancer. A clinical trial at Huntsman Cancer Institute has provided her with hope.
